Havrix 720 Hepatitis A Vaccine 0.5 mL Injection – GSK Havrix 720 is an inactivated Hepatitis A vaccine manufactured by GlaxoSmithKline (GSK). It is designed to provide active immunization against Hepatitis A virus (HAV) infection in children and adolescents. GlobMed India offers international sourcing and export assistance for Havrix 720 vaccine, supporting pharmaceutical distributors, hospitals, healthcare institutions, and authorized importers worldwide. Product Specifications Brand Name: Havrix 720 Generic Name: Inactivated Hepatitis A Vaccine (Adsorbed) IP Manufacturer: GlaxoSmithKline (GSK) Strength: 720 ELISA Units / 0.5 mL Dosage Form: Injectable Suspension Packaging: 10 × 0.5 mL Single-Dose Vials Route: Intramuscular Injection Therapeutic Category: Hepatitis A Vaccine Storage Temperature: 2°C–8°C (Do Not Freeze) Uses and Benefits Havrix 720 helps protect against Hepatitis A, a viral infection affecting the liver. It stimulates the immune system to develop antibodies against the Hepatitis A virus and is used for preventive immunization according to recommended vaccination schedules. Dosage and Storage Havrix 720 is administered by intramuscular injection under medical supervision. The vaccination schedule, including booster doses, should follow approved prescribing guidelines. The vaccine must be stored and transported between 2°C and 8°C without freezing to maintain product quality. Havrix 720 Global Supplier – GlobMed India GlobMed India supports international pharmaceutical procurement with temperature-controlled shipping coordination, export documentation assistance, and competitive quotations based on order requirements. Contact GlobMed India for Havrix 720 vaccine price, bulk supply enquiries, product availability, and international shipping details. For use by qualified healthcare professionals. Supply is subject to applicable pharmaceutical regulations and import requirements.